Clinical Trial Update: An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

View source ↗

Summary

This clinical trials update discusses an Expanded Access IND for Chronic Inflammatory Demyelinating Polyneuropathy. The status indicates the trial is no longer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | Status: NO_LONGER_AVAILABLE